Press release
Insomnia Market Share Set for Significant Growth Amid Rising Sleep Disorders and Technological Advancements
Insomnia Market
Explore the market further-request a sample report today: https://www.maximizemarketresearch.com/request-sample/37228/
Market Estimation, Growth Drivers, and Opportunities
As of 2023, the insomnia market was valued at approximately USD 5.2 billion and is projected to reach USD 7.8 billion by 2030, growing at a CAGR of 5.9% during the forecast period. The growth of the market is attributed to multiple factors:
• Rising Insomnia Cases: Increasing mental health issues, longer screen times, and sedentary lifestyles are leading to a surge in sleep disorders.
• Advancements in Therapeutics: The development of new medications, cognitive behavioral therapy (CBT) solutions, and digital therapeutics is expanding treatment options.
• Growing Geriatric Population: Older adults are more prone to insomnia, further driving the need for specialized sleep disorder treatments.
• Expansion of Digital Healthcare: Telemedicine and mobile apps for sleep tracking and CBT have gained traction, offering convenient treatment options.
U.S. Market Trends and Investments
The U.S. continues to be a dominant player in the insomnia market, with significant investments and evolving treatment options. Key trends shaping the market in 2024 include:
• Increase in Digital Sleep Solutions: The adoption of AI-driven sleep-tracking apps and virtual CBT programs has surged, making non-pharmaceutical solutions more accessible.
• Rising Demand for Non-Benzodiazepine Medications: Consumers and healthcare professionals are shifting toward safer, non-habit-forming sleep aids such as melatonin receptor agonists and dual orexin receptor antagonists (DORAs).
• Investment in Behavioral Therapies: Leading pharmaceutical and tech companies have invested in AI-powered behavioral therapy applications, promoting holistic treatment.
• Retail Expansion of OTC Sleep Aids: Major pharmacy chains and e-commerce platforms have increased their range of over-the-counter (OTC) sleep products, boosting market penetration.
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report:https://www.maximizemarketresearch.com/market-report/insomnia-market/37228/
Market Segmentation and Dominant Shares
The insomnia market is segmented based on treatment type, drug class, and distribution channel. The dominant market shares include:
• By Treatment Type:
o Pharmacological Treatment: Continues to dominate due to the high adoption of prescription and OTC sleep medications.
• By Drug Class:
o Non-Benzodiazepines: Holds the largest market share as safer alternatives to traditional sleep aids gain traction.
• By Distribution Channel:
o Hospital Pharmacies: Account for the largest revenue share due to the increased number of sleep disorder diagnoses and prescriptions.
Competitive Analysis
The insomnia market is highly competitive, with key players investing in new drug development, digital health solutions, and strategic collaborations. The top five companies leading the industry include:
1. Eisai Co., Ltd.
o Innovation: Developed Dayvigo (lemborexant), a DORA that provides improved sleep patterns without dependency concerns.
o Expansion Plans: Increasing investments in distribution and new research for next-generation sleep therapies.
2. Merck & Co., Inc.
o Product Development: Launched Belsomra (suvorexant), a DORA that is gaining popularity as a safer alternative to benzodiazepines.
o Research Initiatives: Exploring AI-based solutions for sleep disorder treatments.
3. Sanofi S.A.
o Market Strategy: Focused on over-the-counter (OTC) sleep aids and expanding consumer education initiatives.
o Recent Policy Changes: Strengthened its commitment to reducing dependency risks in prescription sleep medications.
4. Pfizer Inc.
o Investment in Neuroscience: Expanding research in sleep-related neuroscience and mental health, with a focus on innovative drug formulations.
o Technological Integration: Partnering with digital health companies to develop AI-powered sleep diagnostics.
5. Takeda Pharmaceutical Company
o Expansion: Strengthening its position in key markets through acquisitions and partnerships in the sleep disorder segment.
o New Research: Developing novel compounds for long-term sleep stability and reduced side effects.
Seeking more data? Request a sample report or inquire for detailed insights: https://www.maximizemarketresearch.com/request-sample/37228/
Regional Analysis
• United States:
o Market Share: One of the largest markets for insomnia treatment due to the high prevalence of sleep disorders.
o Government Policies: Increased funding for mental health programs and sleep disorder awareness campaigns.
o Growth Factors: Expansion of telemedicine and digital therapeutics is driving new treatment adoption.
• United Kingdom:
o Market Trends: Growing preference for non-pharmacological interventions such as CBT and mindfulness-based sleep therapies.
o Government Support: NHS initiatives promoting mental well-being and sleep hygiene awareness.
o Consumer Behavior: Rising demand for herbal and natural sleep aids over prescription medications.
• Germany:
o Market Dynamics: A strong pharmaceutical industry presence is fueling innovation in prescription sleep medications.
o Regulatory Environment: Strict regulations on prescription sleep drugs encourage safer alternatives.
o Corporate Influence: Leading European pharmaceutical firms are investing in next-generation sleep therapeutics.
• France:
o Consumer Trends: High adoption of alternative therapies, including herbal and homeopathic sleep solutions.
o Sustainability Initiatives: Companies are focusing on plant-based and biodegradable sleep aid formulations.
o Market Growth Factors: Government-funded sleep disorder awareness programs increasing diagnosis rates.
• Japan:
o Market Position: Advanced technological solutions for sleep tracking and therapy are gaining popularity.
o Government Policies: Investments in mental health support programs and workplace wellness initiatives.
o Technological Advancements: AI-driven sleep solutions integrated into healthcare systems.
• China:
o Emerging Market: Rapidly growing due to urbanization and increased awareness of mental health.
o Government Policies: Support for traditional Chinese medicine (TCM) alongside modern pharmacological solutions.
o Economic Factors: Rising disposable income and improved healthcare infrastructure boosting demand.
Conclusion
The insomnia market is set for continued growth, driven by rising cases of sleep disorders, advancements in treatment options, and the increasing adoption of digital health solutions. Companies investing in safer, non-addictive medications, AI-driven sleep monitoring tools, and cognitive behavioral therapy (CBT) solutions are expected to gain a competitive advantage. As government regulations and healthcare policies evolve, the market presents significant opportunities for pharmaceutical firms, technology developers, and healthcare providers.
Check out our trending studies to understand industry shifts:
♦Wearable Pregnancy Devices Market https://www.maximizemarketresearch.com/market-report/global-wearable-pregnancy-devices-market/84933/
♦global Bioremediation Technology https://www.maximizemarketresearch.com/market-report/global-bioremediation-technology-services-market/72113/
♦global Mobile health market https://www.maximizemarketresearch.com/market-report/mhealth-market/606/
♦Pre Clinical Imaging Market https://www.maximizemarketresearch.com/market-report/global-pre-cinical-imaging-market/8476/
♦CRISPR And Cas Genes Market https://www.maximizemarketresearch.com/market-report/crispr-and-cas-genes-market/127232/
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
sales@maximizemarketresearch.com
www.maximizemarketresearch.com
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market Share Set for Significant Growth Amid Rising Sleep Disorders and Technological Advancements here
News-ID: 3915139 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR …
According to a new report by Maximize Market Research, the global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032, growing at a CAGR of 6.13%. A major surge in biopharmaceutical R&D and oncology-focused studies is driving the global clinical trials market toward nearly USD 88.26 billion by 2032 at a 6.13% CAGR.
► Get a sample of the…
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5 …
Turbo Trainer Market size was valued at USD 281.52 Mn. in 2024 and the total Turbo Trainer revenue is expected to grow at 5.16% through 2025 to 2032, reaching nearly USD 421.03 Mn.
Turbo Trainer Market Overview:
The Turbo Trainer Market is witnessing significant growth as fitness enthusiasts increasingly adopt indoor cycling equipment for year-round training. Turbo trainers, which allow users to convert regular bicycles into stationary exercise machines, have become essential…
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of …
Sodium Acetate Market size was valued at USD 206.17 Million in 2024, and the total revenue is expected to grow at CAGR of 7 % from 2025 to 2032, reaching nearly USD 354.24 Million.
Sodium Acetate Market Overview:
The Sodium Acetate Market is experiencing steady growth due to its widespread applications across industries such as food and beverage, pharmaceuticals, textiles, and chemical manufacturing. Sodium acetate, a versatile salt of acetic acid, is…
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR - "India Tire …
According to a new report by Maximize Market Research, the India tire market was valued at approximately USD 13.4 billion in 2024 and is expected to climb to USD 27.6 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.6 %. The growth is underpinned by increasing automotive production, growing replacement demand, and rising adoption of radial tyres.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/21022/
♦ Key Highlights
Market size…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
